Both mucosal-associated invariant and natural killer T-cell deficiency in multiple myeloma can be countered by PD-1 inhibition Article Swipe
Mérédis Favreau
,
Koen Venken
,
Sylvia Faict
,
Ken Maes
,
Kim De Veirman
,
Elke De Bruyne
,
Xavier Leleu
,
Louis Boon
,
Dirk Elewaut
,
Karin Vanderkerken
,
Eline Menu
·
YOU?
·
· 2017
· Open Access
·
· DOI: https://doi.org/10.3324/haematol.2017.163758
YOU?
·
· 2017
· Open Access
·
· DOI: https://doi.org/10.3324/haematol.2017.163758
Both mucosal-associated invariant and natural killer T-cell deficiency in multiple myeloma can be countered by PD-1 inhibitionMucosal associated invariant T (MAIT) cells primarily contribute to immune defense against infectious pathogens and regulate pathogenesis of various inflammatory diseases. 1They are innate-like T lymphocytes expressing an invariant TCR Vα7.2-Jα33 chain in humans and displaying high expression levels of CD161 and IL-18R.They are primarily localized in mucosal tissue and respond to vitamin B2 metabolites in an MHC class 1b (MR1)-dependent manner. 1 Despite a different ontogeny, MAIT cells share a close lineage relationship with invariant natural killer T (iNKT) cells, another invariant T-cell subset recognizing glycolipids and important for anti-tumor immunity. 1,2Moreover, it has been suggested that they share a common niche and could therefore be functionally redundant. 3Recently, MAIT cells have been implicated in cancer and were shown to support antitumor immunity; 4 however, their exact role has not been well explored.Until now, most reports on involvement of MAIT cells in cancer have been limited to mucosaassociated cancers. 5Recently, however, Wallace et al. reported MAIT cell deficiency in chronic lymphocyte leukemia (CLL), suggesting a possible involvement of MAIT cells in hematologic malignancies as well. 4Further investigation of MAIT cell functionality in cancer patients beyond mucosa-associated malignancies is, therefore, warranted.In multiple myeloma (MM), invariant T cells such as iNKT cells have been reported by us and others to be deficient. 6This has not yet been investigated for MAIT cells and whether they prove to be haematologica 2017;
Related Topics
Concepts
Immunology
Pathogenesis
Immune system
T-cell receptor
Multiple myeloma
Innate immune system
Biology
Natural killer T cell
T cell
Metadata
- Type
- letter
- Language
- en
- Landing Page
- https://doi.org/10.3324/haematol.2017.163758
- http://www.haematologica.org/content/haematol/102/7/e266.full.pdf
- OA Status
- gold
- Cited By
- 35
- References
- 16
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2604599595
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2604599595Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.3324/haematol.2017.163758Digital Object Identifier
- Title
-
Both mucosal-associated invariant and natural killer T-cell deficiency in multiple myeloma can be countered by PD-1 inhibitionWork title
- Type
-
letterOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2017Year of publication
- Publication date
-
2017-04-06Full publication date if available
- Authors
-
Mérédis Favreau, Koen Venken, Sylvia Faict, Ken Maes, Kim De Veirman, Elke De Bruyne, Xavier Leleu, Louis Boon, Dirk Elewaut, Karin Vanderkerken, Eline MenuList of authors in order
- Landing page
-
https://doi.org/10.3324/haematol.2017.163758Publisher landing page
- PDF URL
-
https://www.haematologica.org/content/haematol/102/7/e266.full.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.haematologica.org/content/haematol/102/7/e266.full.pdfDirect OA link when available
- Concepts
-
Immunology, Pathogenesis, Immune system, T-cell receptor, Multiple myeloma, Innate immune system, Biology, Natural killer T cell, T cellTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
35Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 6, 2024: 2, 2023: 3, 2022: 10, 2021: 4Per-year citation counts (last 5 years)
- References (count)
-
16Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2604599595 |
|---|---|
| doi | https://doi.org/10.3324/haematol.2017.163758 |
| ids.doi | https://doi.org/10.3324/haematol.2017.163758 |
| ids.mag | 2604599595 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/28385777 |
| ids.openalex | https://openalex.org/W2604599595 |
| fwci | 1.32734209 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D015415 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Biomarkers |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D015870 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Gene Expression |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D006801 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Humans |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D016130 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Immunophenotyping |
| mesh[4].qualifier_ui | Q000166 |
| mesh[4].descriptor_ui | D009092 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | cytology |
| mesh[4].descriptor_name | Mucous Membrane |
| mesh[5].qualifier_ui | Q000276 |
| mesh[5].descriptor_ui | D009092 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | immunology |
| mesh[5].descriptor_name | Mucous Membrane |
| mesh[6].qualifier_ui | Q000378 |
| mesh[6].descriptor_ui | D009092 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | metabolism |
| mesh[6].descriptor_name | Mucous Membrane |
| mesh[7].qualifier_ui | Q000175 |
| mesh[7].descriptor_ui | D009101 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | diagnosis |
| mesh[7].descriptor_name | Multiple Myeloma |
| mesh[8].qualifier_ui | Q000276 |
| mesh[8].descriptor_ui | D009101 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | immunology |
| mesh[8].descriptor_name | Multiple Myeloma |
| mesh[9].qualifier_ui | Q000378 |
| mesh[9].descriptor_ui | D009101 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | metabolism |
| mesh[9].descriptor_name | Multiple Myeloma |
| mesh[10].qualifier_ui | Q000276 |
| mesh[10].descriptor_ui | D055611 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | immunology |
| mesh[10].descriptor_name | Natural Killer T-Cells |
| mesh[11].qualifier_ui | Q000378 |
| mesh[11].descriptor_ui | D055611 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | metabolism |
| mesh[11].descriptor_name | Natural Killer T-Cells |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D010641 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Phenotype |
| mesh[13].qualifier_ui | Q000037 |
| mesh[13].descriptor_ui | D061026 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | antagonists & inhibitors |
| mesh[13].descriptor_name | Programmed Cell Death 1 Receptor |
| mesh[14].qualifier_ui | Q000235 |
| mesh[14].descriptor_ui | D061026 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | genetics |
| mesh[14].descriptor_name | Programmed Cell Death 1 Receptor |
| mesh[15].qualifier_ui | Q000378 |
| mesh[15].descriptor_ui | D061026 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | metabolism |
| mesh[15].descriptor_name | Programmed Cell Death 1 Receptor |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D015415 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Biomarkers |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D015870 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Gene Expression |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D006801 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Humans |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D016130 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Immunophenotyping |
| mesh[20].qualifier_ui | Q000166 |
| mesh[20].descriptor_ui | D009092 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | cytology |
| mesh[20].descriptor_name | Mucous Membrane |
| mesh[21].qualifier_ui | Q000276 |
| mesh[21].descriptor_ui | D009092 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | immunology |
| mesh[21].descriptor_name | Mucous Membrane |
| mesh[22].qualifier_ui | Q000378 |
| mesh[22].descriptor_ui | D009092 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | metabolism |
| mesh[22].descriptor_name | Mucous Membrane |
| mesh[23].qualifier_ui | Q000175 |
| mesh[23].descriptor_ui | D009101 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | diagnosis |
| mesh[23].descriptor_name | Multiple Myeloma |
| mesh[24].qualifier_ui | Q000276 |
| mesh[24].descriptor_ui | D009101 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | immunology |
| mesh[24].descriptor_name | Multiple Myeloma |
| mesh[25].qualifier_ui | Q000378 |
| mesh[25].descriptor_ui | D009101 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | metabolism |
| mesh[25].descriptor_name | Multiple Myeloma |
| mesh[26].qualifier_ui | Q000276 |
| mesh[26].descriptor_ui | D055611 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | immunology |
| mesh[26].descriptor_name | Natural Killer T-Cells |
| mesh[27].qualifier_ui | Q000378 |
| mesh[27].descriptor_ui | D055611 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | metabolism |
| mesh[27].descriptor_name | Natural Killer T-Cells |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D010641 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Phenotype |
| mesh[29].qualifier_ui | Q000037 |
| mesh[29].descriptor_ui | D061026 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | antagonists & inhibitors |
| mesh[29].descriptor_name | Programmed Cell Death 1 Receptor |
| mesh[30].qualifier_ui | Q000235 |
| mesh[30].descriptor_ui | D061026 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | genetics |
| mesh[30].descriptor_name | Programmed Cell Death 1 Receptor |
| mesh[31].qualifier_ui | Q000378 |
| mesh[31].descriptor_ui | D061026 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | metabolism |
| mesh[31].descriptor_name | Programmed Cell Death 1 Receptor |
| type | letter |
| title | Both mucosal-associated invariant and natural killer T-cell deficiency in multiple myeloma can be countered by PD-1 inhibition |
| biblio.issue | 7 |
| biblio.volume | 102 |
| biblio.last_page | e270 |
| biblio.first_page | e266 |
| topics[0].id | https://openalex.org/T11020 |
| topics[0].field.id | https://openalex.org/fields/24 |
| topics[0].field.display_name | Immunology and Microbiology |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2403 |
| topics[0].subfield.display_name | Immunology |
| topics[0].display_name | Immune Cell Function and Interaction |
| topics[1].id | https://openalex.org/T10031 |
| topics[1].field.id | https://openalex.org/fields/24 |
| topics[1].field.display_name | Immunology and Microbiology |
| topics[1].score | 0.9995999932289124 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2403 |
| topics[1].subfield.display_name | Immunology |
| topics[1].display_name | T-cell and B-cell Immunology |
| topics[2].id | https://openalex.org/T10580 |
| topics[2].field.id | https://openalex.org/fields/24 |
| topics[2].field.display_name | Immunology and Microbiology |
| topics[2].score | 0.9965999722480774 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2403 |
| topics[2].subfield.display_name | Immunology |
| topics[2].display_name | Immunotherapy and Immune Responses |
| is_xpac | False |
| apc_list.value | 2000 |
| apc_list.currency | EUR |
| apc_list.value_usd | 2157 |
| apc_paid.value | 2000 |
| apc_paid.currency | EUR |
| apc_paid.value_usd | 2157 |
| concepts[0].id | https://openalex.org/C203014093 |
| concepts[0].level | 1 |
| concepts[0].score | 0.6978243589401245 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[0].display_name | Immunology |
| concepts[1].id | https://openalex.org/C2780942790 |
| concepts[1].level | 2 |
| concepts[1].score | 0.5857351422309875 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q372016 |
| concepts[1].display_name | Pathogenesis |
| concepts[2].id | https://openalex.org/C8891405 |
| concepts[2].level | 2 |
| concepts[2].score | 0.5586321949958801 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q1059 |
| concepts[2].display_name | Immune system |
| concepts[3].id | https://openalex.org/C19317047 |
| concepts[3].level | 4 |
| concepts[3].score | 0.5356241464614868 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q412037 |
| concepts[3].display_name | T-cell receptor |
| concepts[4].id | https://openalex.org/C2776364478 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5180652141571045 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q467635 |
| concepts[4].display_name | Multiple myeloma |
| concepts[5].id | https://openalex.org/C136449434 |
| concepts[5].level | 3 |
| concepts[5].score | 0.48996201157569885 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q428253 |
| concepts[5].display_name | Innate immune system |
| concepts[6].id | https://openalex.org/C86803240 |
| concepts[6].level | 0 |
| concepts[6].score | 0.4580255448818207 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[6].display_name | Biology |
| concepts[7].id | https://openalex.org/C139563560 |
| concepts[7].level | 4 |
| concepts[7].score | 0.41433244943618774 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q224930 |
| concepts[7].display_name | Natural killer T cell |
| concepts[8].id | https://openalex.org/C2776090121 |
| concepts[8].level | 3 |
| concepts[8].score | 0.3816419243812561 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q193529 |
| concepts[8].display_name | T cell |
| keywords[0].id | https://openalex.org/keywords/immunology |
| keywords[0].score | 0.6978243589401245 |
| keywords[0].display_name | Immunology |
| keywords[1].id | https://openalex.org/keywords/pathogenesis |
| keywords[1].score | 0.5857351422309875 |
| keywords[1].display_name | Pathogenesis |
| keywords[2].id | https://openalex.org/keywords/immune-system |
| keywords[2].score | 0.5586321949958801 |
| keywords[2].display_name | Immune system |
| keywords[3].id | https://openalex.org/keywords/t-cell-receptor |
| keywords[3].score | 0.5356241464614868 |
| keywords[3].display_name | T-cell receptor |
| keywords[4].id | https://openalex.org/keywords/multiple-myeloma |
| keywords[4].score | 0.5180652141571045 |
| keywords[4].display_name | Multiple myeloma |
| keywords[5].id | https://openalex.org/keywords/innate-immune-system |
| keywords[5].score | 0.48996201157569885 |
| keywords[5].display_name | Innate immune system |
| keywords[6].id | https://openalex.org/keywords/biology |
| keywords[6].score | 0.4580255448818207 |
| keywords[6].display_name | Biology |
| keywords[7].id | https://openalex.org/keywords/natural-killer-t-cell |
| keywords[7].score | 0.41433244943618774 |
| keywords[7].display_name | Natural killer T cell |
| keywords[8].id | https://openalex.org/keywords/t-cell |
| keywords[8].score | 0.3816419243812561 |
| keywords[8].display_name | T cell |
| language | en |
| locations[0].id | doi:10.3324/haematol.2017.163758 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2752781272 |
| locations[0].source.issn | 0390-6078, 1592-8721 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 0390-6078 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Haematologica |
| locations[0].source.host_organization | https://openalex.org/P4310317774 |
| locations[0].source.host_organization_name | Ferrata Storti Foundation |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310317774 |
| locations[0].license | |
| locations[0].pdf_url | http://www.haematologica.org/content/haematol/102/7/e266.full.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Haematologica |
| locations[0].landing_page_url | https://doi.org/10.3324/haematol.2017.163758 |
| locations[1].id | pmid:28385777 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Haematologica |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/28385777 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:5566052 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Haematologica |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/5566052 |
| locations[3].id | pmh:oai:archive.ugent.be:8555826 |
| locations[3].is_oa | False |
| locations[3].source.id | https://openalex.org/S4306400477 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | Ghent University Academic Bibliography (Ghent University) |
| locations[3].source.host_organization | https://openalex.org/I32597200 |
| locations[3].source.host_organization_name | Ghent University |
| locations[3].source.host_organization_lineage | https://openalex.org/I32597200 |
| locations[3].license | |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | journalArticle |
| locations[3].license_id | |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | HAEMATOLOGICA |
| locations[3].landing_page_url | https://biblio.ugent.be/publication/8555826 |
| locations[4].id | pmh:oai:doaj.org/article:61ea36d422bd4d2e8922c913559ebcba |
| locations[4].is_oa | False |
| locations[4].source.id | https://openalex.org/S4306401280 |
| locations[4].source.issn | |
| locations[4].source.type | repository |
| locations[4].source.is_oa | False |
| locations[4].source.issn_l | |
| locations[4].source.is_core | False |
| locations[4].source.is_in_doaj | False |
| locations[4].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[4].source.host_organization | |
| locations[4].source.host_organization_name | |
| locations[4].source.host_organization_lineage | |
| locations[4].license | |
| locations[4].pdf_url | |
| locations[4].version | submittedVersion |
| locations[4].raw_type | article |
| locations[4].license_id | |
| locations[4].is_accepted | False |
| locations[4].is_published | False |
| locations[4].raw_source_name | Haematologica, Vol 102, Iss 7 (2017) |
| locations[4].landing_page_url | https://doaj.org/article/61ea36d422bd4d2e8922c913559ebcba |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5108382646 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Mérédis Favreau |
| authorships[0].countries | BE |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I13469542 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel (VUB), Belgium |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I32597200, https://openalex.org/I4210139803 |
| authorships[0].affiliations[1].raw_affiliation_string | Unit for Molecular Immunology and Inflammation, VIB Inflammation Research Center, Ghent University, Belgium |
| authorships[0].affiliations[2].institution_ids | https://openalex.org/I2801227569 |
| authorships[0].affiliations[2].raw_affiliation_string | Department of Rheumatology, Ghent University Hospital, Belgium |
| authorships[0].institutions[0].id | https://openalex.org/I32597200 |
| authorships[0].institutions[0].ror | https://ror.org/00cv9y106 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I32597200 |
| authorships[0].institutions[0].country_code | BE |
| authorships[0].institutions[0].display_name | Ghent University |
| authorships[0].institutions[1].id | https://openalex.org/I2801227569 |
| authorships[0].institutions[1].ror | https://ror.org/00xmkp704 |
| authorships[0].institutions[1].type | healthcare |
| authorships[0].institutions[1].lineage | https://openalex.org/I2801227569 |
| authorships[0].institutions[1].country_code | BE |
| authorships[0].institutions[1].display_name | Ghent University Hospital |
| authorships[0].institutions[2].id | https://openalex.org/I4210139803 |
| authorships[0].institutions[2].ror | https://ror.org/04q4ydz28 |
| authorships[0].institutions[2].type | facility |
| authorships[0].institutions[2].lineage | https://openalex.org/I2802017950, https://openalex.org/I32597200, https://openalex.org/I4210139803 |
| authorships[0].institutions[2].country_code | BE |
| authorships[0].institutions[2].display_name | VIB-UGent Center for Inflammation Research |
| authorships[0].institutions[3].id | https://openalex.org/I13469542 |
| authorships[0].institutions[3].ror | https://ror.org/006e5kg04 |
| authorships[0].institutions[3].type | education |
| authorships[0].institutions[3].lineage | https://openalex.org/I13469542 |
| authorships[0].institutions[3].country_code | BE |
| authorships[0].institutions[3].display_name | Vrije Universiteit Brussel |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Mérédis Favreau |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel (VUB), Belgium, Department of Rheumatology, Ghent University Hospital, Belgium, Unit for Molecular Immunology and Inflammation, VIB Inflammation Research Center, Ghent University, Belgium |
| authorships[1].author.id | https://openalex.org/A5000551742 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-4950-386X |
| authorships[1].author.display_name | Koen Venken |
| authorships[1].countries | BE |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I32597200, https://openalex.org/I4210139803 |
| authorships[1].affiliations[0].raw_affiliation_string | Unit for Molecular Immunology and Inflammation, VIB Inflammation Research Center, Ghent University, Belgium |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I2801227569 |
| authorships[1].affiliations[1].raw_affiliation_string | Department of Rheumatology, Ghent University Hospital, Belgium |
| authorships[1].institutions[0].id | https://openalex.org/I32597200 |
| authorships[1].institutions[0].ror | https://ror.org/00cv9y106 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I32597200 |
| authorships[1].institutions[0].country_code | BE |
| authorships[1].institutions[0].display_name | Ghent University |
| authorships[1].institutions[1].id | https://openalex.org/I2801227569 |
| authorships[1].institutions[1].ror | https://ror.org/00xmkp704 |
| authorships[1].institutions[1].type | healthcare |
| authorships[1].institutions[1].lineage | https://openalex.org/I2801227569 |
| authorships[1].institutions[1].country_code | BE |
| authorships[1].institutions[1].display_name | Ghent University Hospital |
| authorships[1].institutions[2].id | https://openalex.org/I4210139803 |
| authorships[1].institutions[2].ror | https://ror.org/04q4ydz28 |
| authorships[1].institutions[2].type | facility |
| authorships[1].institutions[2].lineage | https://openalex.org/I2802017950, https://openalex.org/I32597200, https://openalex.org/I4210139803 |
| authorships[1].institutions[2].country_code | BE |
| authorships[1].institutions[2].display_name | VIB-UGent Center for Inflammation Research |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Koen Venken |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Rheumatology, Ghent University Hospital, Belgium, Unit for Molecular Immunology and Inflammation, VIB Inflammation Research Center, Ghent University, Belgium |
| authorships[2].author.id | https://openalex.org/A5052090082 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-7792-6886 |
| authorships[2].author.display_name | Sylvia Faict |
| authorships[2].countries | BE |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I13469542 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel (VUB), Belgium |
| authorships[2].institutions[0].id | https://openalex.org/I13469542 |
| authorships[2].institutions[0].ror | https://ror.org/006e5kg04 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I13469542 |
| authorships[2].institutions[0].country_code | BE |
| authorships[2].institutions[0].display_name | Vrije Universiteit Brussel |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Sylvia Faict |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel (VUB), Belgium |
| authorships[3].author.id | https://openalex.org/A5091159768 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-8906-2790 |
| authorships[3].author.display_name | Ken Maes |
| authorships[3].countries | BE |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I13469542 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel (VUB), Belgium |
| authorships[3].institutions[0].id | https://openalex.org/I13469542 |
| authorships[3].institutions[0].ror | https://ror.org/006e5kg04 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I13469542 |
| authorships[3].institutions[0].country_code | BE |
| authorships[3].institutions[0].display_name | Vrije Universiteit Brussel |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Ken Maes |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel (VUB), Belgium |
| authorships[4].author.id | https://openalex.org/A5069262831 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-1313-6121 |
| authorships[4].author.display_name | Kim De Veirman |
| authorships[4].countries | BE |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I13469542 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel (VUB), Belgium |
| authorships[4].institutions[0].id | https://openalex.org/I13469542 |
| authorships[4].institutions[0].ror | https://ror.org/006e5kg04 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I13469542 |
| authorships[4].institutions[0].country_code | BE |
| authorships[4].institutions[0].display_name | Vrije Universiteit Brussel |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Kim De Veirman |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel (VUB), Belgium |
| authorships[5].author.id | https://openalex.org/A5027619485 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-4012-4617 |
| authorships[5].author.display_name | Elke De Bruyne |
| authorships[5].countries | BE |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I13469542 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel (VUB), Belgium |
| authorships[5].institutions[0].id | https://openalex.org/I13469542 |
| authorships[5].institutions[0].ror | https://ror.org/006e5kg04 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I13469542 |
| authorships[5].institutions[0].country_code | BE |
| authorships[5].institutions[0].display_name | Vrije Universiteit Brussel |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Elke De Bruyne |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel (VUB), Belgium |
| authorships[6].author.id | https://openalex.org/A5048560248 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-9822-4170 |
| authorships[6].author.display_name | Xavier Leleu |
| authorships[6].affiliations[0].raw_affiliation_string | Service d'Hématologie et Thérapie Cellulaire, Pôle Régional de Cancérologie, Hopital de la Miléterie, 86021 Poitiers, France |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Xavier Leleu |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Service d'Hématologie et Thérapie Cellulaire, Pôle Régional de Cancérologie, Hopital de la Miléterie, 86021 Poitiers, France |
| authorships[7].author.id | https://openalex.org/A5025153030 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-0937-9171 |
| authorships[7].author.display_name | Louis Boon |
| authorships[7].countries | NL |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210108500 |
| authorships[7].affiliations[0].raw_affiliation_string | Bioceros, Utrecht, The Netherlands |
| authorships[7].institutions[0].id | https://openalex.org/I4210108500 |
| authorships[7].institutions[0].ror | https://ror.org/02h8kp866 |
| authorships[7].institutions[0].type | company |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210108500 |
| authorships[7].institutions[0].country_code | NL |
| authorships[7].institutions[0].display_name | Polpharma Biologics (Netherlands) |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Louis Boon |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Bioceros, Utrecht, The Netherlands |
| authorships[8].author.id | https://openalex.org/A5089769631 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-7468-974X |
| authorships[8].author.display_name | Dirk Elewaut |
| authorships[8].countries | BE |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I2801227569 |
| authorships[8].affiliations[0].raw_affiliation_string | Department of Rheumatology, Ghent University Hospital, Belgium |
| authorships[8].affiliations[1].institution_ids | https://openalex.org/I32597200, https://openalex.org/I4210139803 |
| authorships[8].affiliations[1].raw_affiliation_string | Unit for Molecular Immunology and Inflammation, VIB Inflammation Research Center, Ghent University, Belgium |
| authorships[8].institutions[0].id | https://openalex.org/I32597200 |
| authorships[8].institutions[0].ror | https://ror.org/00cv9y106 |
| authorships[8].institutions[0].type | education |
| authorships[8].institutions[0].lineage | https://openalex.org/I32597200 |
| authorships[8].institutions[0].country_code | BE |
| authorships[8].institutions[0].display_name | Ghent University |
| authorships[8].institutions[1].id | https://openalex.org/I2801227569 |
| authorships[8].institutions[1].ror | https://ror.org/00xmkp704 |
| authorships[8].institutions[1].type | healthcare |
| authorships[8].institutions[1].lineage | https://openalex.org/I2801227569 |
| authorships[8].institutions[1].country_code | BE |
| authorships[8].institutions[1].display_name | Ghent University Hospital |
| authorships[8].institutions[2].id | https://openalex.org/I4210139803 |
| authorships[8].institutions[2].ror | https://ror.org/04q4ydz28 |
| authorships[8].institutions[2].type | facility |
| authorships[8].institutions[2].lineage | https://openalex.org/I2802017950, https://openalex.org/I32597200, https://openalex.org/I4210139803 |
| authorships[8].institutions[2].country_code | BE |
| authorships[8].institutions[2].display_name | VIB-UGent Center for Inflammation Research |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Dirk Elewaut |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Department of Rheumatology, Ghent University Hospital, Belgium, Unit for Molecular Immunology and Inflammation, VIB Inflammation Research Center, Ghent University, Belgium |
| authorships[9].author.id | https://openalex.org/A5014026887 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-2137-7179 |
| authorships[9].author.display_name | Karin Vanderkerken |
| authorships[9].countries | BE |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I13469542 |
| authorships[9].affiliations[0].raw_affiliation_string | Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel (VUB), Belgium |
| authorships[9].institutions[0].id | https://openalex.org/I13469542 |
| authorships[9].institutions[0].ror | https://ror.org/006e5kg04 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I13469542 |
| authorships[9].institutions[0].country_code | BE |
| authorships[9].institutions[0].display_name | Vrije Universiteit Brussel |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Karin Vanderkerken |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel (VUB), Belgium |
| authorships[10].author.id | https://openalex.org/A5003658156 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-0805-6581 |
| authorships[10].author.display_name | Eline Menu |
| authorships[10].countries | BE |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I13469542 |
| authorships[10].affiliations[0].raw_affiliation_string | Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel (VUB), Belgium |
| authorships[10].institutions[0].id | https://openalex.org/I13469542 |
| authorships[10].institutions[0].ror | https://ror.org/006e5kg04 |
| authorships[10].institutions[0].type | education |
| authorships[10].institutions[0].lineage | https://openalex.org/I13469542 |
| authorships[10].institutions[0].country_code | BE |
| authorships[10].institutions[0].display_name | Vrije Universiteit Brussel |
| authorships[10].author_position | last |
| authorships[10].raw_author_name | Eline Menu |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel (VUB), Belgium |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | http://www.haematologica.org/content/haematol/102/7/e266.full.pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Both mucosal-associated invariant and natural killer T-cell deficiency in multiple myeloma can be countered by PD-1 inhibition |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11020 |
| primary_topic.field.id | https://openalex.org/fields/24 |
| primary_topic.field.display_name | Immunology and Microbiology |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2403 |
| primary_topic.subfield.display_name | Immunology |
| primary_topic.display_name | Immune Cell Function and Interaction |
| related_works | https://openalex.org/W2040128205, https://openalex.org/W2060075608, https://openalex.org/W2026444950, https://openalex.org/W2092033815, https://openalex.org/W2168929838, https://openalex.org/W2037024992, https://openalex.org/W2140205174, https://openalex.org/W2064485034, https://openalex.org/W104003022, https://openalex.org/W1971240700 |
| cited_by_count | 35 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 6 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 2 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 3 |
| counts_by_year[3].year | 2022 |
| counts_by_year[3].cited_by_count | 10 |
| counts_by_year[4].year | 2021 |
| counts_by_year[4].cited_by_count | 4 |
| counts_by_year[5].year | 2020 |
| counts_by_year[5].cited_by_count | 6 |
| counts_by_year[6].year | 2019 |
| counts_by_year[6].cited_by_count | 2 |
| counts_by_year[7].year | 2018 |
| counts_by_year[7].cited_by_count | 2 |
| locations_count | 5 |
| best_oa_location.id | doi:10.3324/haematol.2017.163758 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2752781272 |
| best_oa_location.source.issn | 0390-6078, 1592-8721 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 0390-6078 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Haematologica |
| best_oa_location.source.host_organization | https://openalex.org/P4310317774 |
| best_oa_location.source.host_organization_name | Ferrata Storti Foundation |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310317774 |
| best_oa_location.license | |
| best_oa_location.pdf_url | http://www.haematologica.org/content/haematol/102/7/e266.full.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Haematologica |
| best_oa_location.landing_page_url | https://doi.org/10.3324/haematol.2017.163758 |
| primary_location.id | doi:10.3324/haematol.2017.163758 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2752781272 |
| primary_location.source.issn | 0390-6078, 1592-8721 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 0390-6078 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Haematologica |
| primary_location.source.host_organization | https://openalex.org/P4310317774 |
| primary_location.source.host_organization_name | Ferrata Storti Foundation |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310317774 |
| primary_location.license | |
| primary_location.pdf_url | http://www.haematologica.org/content/haematol/102/7/e266.full.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Haematologica |
| primary_location.landing_page_url | https://doi.org/10.3324/haematol.2017.163758 |
| publication_date | 2017-04-06 |
| publication_year | 2017 |
| referenced_works | https://openalex.org/W2526319073, https://openalex.org/W2072905311, https://openalex.org/W2496533700, https://openalex.org/W2073247934, https://openalex.org/W2117410945, https://openalex.org/W2413647814, https://openalex.org/W1930123064, https://openalex.org/W1994087084, https://openalex.org/W2090777237, https://openalex.org/W2011550778, https://openalex.org/W2163606879, https://openalex.org/W2059229059, https://openalex.org/W2297852109, https://openalex.org/W2008734511, https://openalex.org/W2491833399, https://openalex.org/W2552702049 |
| referenced_works_count | 16 |
| abstract_inverted_index.1 | 78 |
| abstract_inverted_index.4 | 140 |
| abstract_inverted_index.T | 19, 40, 94, 211 |
| abstract_inverted_index.a | 80, 86, 116, 181 |
| abstract_inverted_index.1b | 75 |
| abstract_inverted_index.B2 | 69 |
| abstract_inverted_index.an | 43, 72 |
| abstract_inverted_index.as | 190, 214 |
| abstract_inverted_index.be | 12, 122, 225, 241 |
| abstract_inverted_index.by | 14, 220 |
| abstract_inverted_index.et | 169 |
| abstract_inverted_index.in | 8, 48, 62, 71, 131, 158, 175, 187, 198 |
| abstract_inverted_index.it | 109 |
| abstract_inverted_index.of | 33, 55, 155, 184, 194 |
| abstract_inverted_index.on | 153 |
| abstract_inverted_index.to | 24, 67, 136, 163, 224, 240 |
| abstract_inverted_index.us | 221 |
| abstract_inverted_index.MHC | 73 |
| abstract_inverted_index.TCR | 45 |
| abstract_inverted_index.al. | 170 |
| abstract_inverted_index.and | 3, 30, 50, 57, 65, 103, 119, 133, 222, 236 |
| abstract_inverted_index.are | 38, 59 |
| abstract_inverted_index.can | 11 |
| abstract_inverted_index.for | 105, 233 |
| abstract_inverted_index.has | 110, 145, 228 |
| abstract_inverted_index.is, | 204 |
| abstract_inverted_index.not | 146, 229 |
| abstract_inverted_index.yet | 230 |
| abstract_inverted_index.Both | 0 |
| abstract_inverted_index.MAIT | 83, 126, 156, 172, 185, 195, 234 |
| abstract_inverted_index.PD-1 | 15 |
| abstract_inverted_index.been | 111, 129, 147, 161, 218, 231 |
| abstract_inverted_index.cell | 173, 196 |
| abstract_inverted_index.have | 128, 160, 217 |
| abstract_inverted_index.high | 52 |
| abstract_inverted_index.iNKT | 215 |
| abstract_inverted_index.most | 151 |
| abstract_inverted_index.now, | 150 |
| abstract_inverted_index.role | 144 |
| abstract_inverted_index.such | 213 |
| abstract_inverted_index.that | 113 |
| abstract_inverted_index.they | 114, 238 |
| abstract_inverted_index.well | 148 |
| abstract_inverted_index.were | 134 |
| abstract_inverted_index.with | 90 |
| abstract_inverted_index.(MM), | 209 |
| abstract_inverted_index.1They | 37 |
| abstract_inverted_index.2017; | 243 |
| abstract_inverted_index.6This | 227 |
| abstract_inverted_index.CD161 | 56 |
| abstract_inverted_index.cells | 21, 84, 127, 157, 186, 212, 216, 235 |
| abstract_inverted_index.chain | 47 |
| abstract_inverted_index.class | 74 |
| abstract_inverted_index.close | 87 |
| abstract_inverted_index.could | 120 |
| abstract_inverted_index.exact | 143 |
| abstract_inverted_index.niche | 118 |
| abstract_inverted_index.prove | 239 |
| abstract_inverted_index.share | 85, 115 |
| abstract_inverted_index.shown | 135 |
| abstract_inverted_index.their | 142 |
| abstract_inverted_index.well. | 191 |
| abstract_inverted_index.(CLL), | 179 |
| abstract_inverted_index.(MAIT) | 20 |
| abstract_inverted_index.(iNKT) | 95 |
| abstract_inverted_index.T-cell | 6, 99 |
| abstract_inverted_index.beyond | 201 |
| abstract_inverted_index.cancer | 132, 159, 199 |
| abstract_inverted_index.cells, | 96 |
| abstract_inverted_index.common | 117 |
| abstract_inverted_index.humans | 49 |
| abstract_inverted_index.immune | 25 |
| abstract_inverted_index.killer | 5, 93 |
| abstract_inverted_index.levels | 54 |
| abstract_inverted_index.others | 223 |
| abstract_inverted_index.subset | 100 |
| abstract_inverted_index.tissue | 64 |
| abstract_inverted_index.Despite | 79 |
| abstract_inverted_index.Wallace | 168 |
| abstract_inverted_index.against | 27 |
| abstract_inverted_index.another | 97 |
| abstract_inverted_index.chronic | 176 |
| abstract_inverted_index.defense | 26 |
| abstract_inverted_index.limited | 162 |
| abstract_inverted_index.lineage | 88 |
| abstract_inverted_index.manner. | 77 |
| abstract_inverted_index.mucosal | 63 |
| abstract_inverted_index.myeloma | 10, 208 |
| abstract_inverted_index.natural | 4, 92 |
| abstract_inverted_index.reports | 152 |
| abstract_inverted_index.respond | 66 |
| abstract_inverted_index.support | 137 |
| abstract_inverted_index.various | 34 |
| abstract_inverted_index.vitamin | 68 |
| abstract_inverted_index.whether | 237 |
| abstract_inverted_index.4Further | 192 |
| abstract_inverted_index.cancers. | 165 |
| abstract_inverted_index.however, | 141, 167 |
| abstract_inverted_index.leukemia | 178 |
| abstract_inverted_index.multiple | 9, 207 |
| abstract_inverted_index.patients | 200 |
| abstract_inverted_index.possible | 182 |
| abstract_inverted_index.regulate | 31 |
| abstract_inverted_index.reported | 171, 219 |
| abstract_inverted_index.antitumor | 138 |
| abstract_inverted_index.countered | 13 |
| abstract_inverted_index.different | 81 |
| abstract_inverted_index.diseases. | 36 |
| abstract_inverted_index.immunity. | 107 |
| abstract_inverted_index.immunity; | 139 |
| abstract_inverted_index.important | 104 |
| abstract_inverted_index.invariant | 2, 18, 44, 91, 98, 210 |
| abstract_inverted_index.localized | 61 |
| abstract_inverted_index.ontogeny, | 82 |
| abstract_inverted_index.pathogens | 29 |
| abstract_inverted_index.primarily | 22, 60 |
| abstract_inverted_index.suggested | 112 |
| abstract_inverted_index.therefore | 121 |
| abstract_inverted_index.3Recently, | 125 |
| abstract_inverted_index.5Recently, | 166 |
| abstract_inverted_index.anti-tumor | 106 |
| abstract_inverted_index.associated | 17 |
| abstract_inverted_index.contribute | 23 |
| abstract_inverted_index.deficiency | 7, 174 |
| abstract_inverted_index.deficient. | 226 |
| abstract_inverted_index.displaying | 51 |
| abstract_inverted_index.expressing | 42 |
| abstract_inverted_index.expression | 53 |
| abstract_inverted_index.implicated | 130 |
| abstract_inverted_index.infectious | 28 |
| abstract_inverted_index.lymphocyte | 177 |
| abstract_inverted_index.redundant. | 124 |
| abstract_inverted_index.suggesting | 180 |
| abstract_inverted_index.therefore, | 205 |
| abstract_inverted_index.IL-18R.They | 58 |
| abstract_inverted_index.glycolipids | 102 |
| abstract_inverted_index.hematologic | 188 |
| abstract_inverted_index.innate-like | 39 |
| abstract_inverted_index.involvement | 154, 183 |
| abstract_inverted_index.lymphocytes | 41 |
| abstract_inverted_index.metabolites | 70 |
| abstract_inverted_index.recognizing | 101 |
| abstract_inverted_index.1,2Moreover, | 108 |
| abstract_inverted_index.Vα7.2-Jα33 | 46 |
| abstract_inverted_index.functionally | 123 |
| abstract_inverted_index.inflammatory | 35 |
| abstract_inverted_index.investigated | 232 |
| abstract_inverted_index.malignancies | 189, 203 |
| abstract_inverted_index.pathogenesis | 32 |
| abstract_inverted_index.relationship | 89 |
| abstract_inverted_index.warranted.In | 206 |
| abstract_inverted_index.functionality | 197 |
| abstract_inverted_index.haematologica | 242 |
| abstract_inverted_index.investigation | 193 |
| abstract_inverted_index.explored.Until | 149 |
| abstract_inverted_index.(MR1)-dependent | 76 |
| abstract_inverted_index.mucosaassociated | 164 |
| abstract_inverted_index.inhibitionMucosal | 16 |
| abstract_inverted_index.mucosa-associated | 202 |
| abstract_inverted_index.mucosal-associated | 1 |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 94 |
| countries_distinct_count | 2 |
| institutions_distinct_count | 11 |
| citation_normalized_percentile.value | 0.74659915 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |